Marcel Renn
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Synthetic RIG-I agonist-mediated cancer immunotherapy synergizes with MAP kinase inhibition against BRAF-mutated melanoma.
Journal: Molecular therapy. Nucleic acids
Published: May 15, 2024
RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma.
Journal: Journal of molecular cell biology
Published: March 13, 2022
RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection.
Journal: Molecular therapy. Nucleic acids
Published: August 07, 2021
Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity.
Journal: Journal of medical virology
Published: August 06, 2021
Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions.
Journal: Pharmacology & therapeutics
Published: January 03, 2021
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.
Journal: Nature communications
Published: April 21, 2015
Inflammasome-Dependent Induction of Adaptive NK Cell Memory.
Journal: Immunity
Published: March 26, 2015
Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation.
Journal: Cancer discovery
Published: March 05, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026